| Entry |
|
| Name |
Drospirenone, ethinyl estradiol and levomefolate calcium; Beyaz (TN); Safyral (TN); Tydemy (TN) |
| Product |
|
| Generic |
|
| Component |
|
| Class |
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
|
| Remark |
|
| Efficacy |
Contraceptive, Menstruation disorder agent |
| Comment |
Drospirenone is a substrate of CYP3A4.
|
| Metabolism |
Enzyme: CYP3A4 [HSA: 1576]
|
| Interaction |
|
| Brite |
USP drug classification [BR:br08302]
Contraceptives
Oral Contraceptives Combinations
Drospirenone/ Ethinyl Estradiol/ Levomefolate Calcium
D12130 Drospirenone, ethinyl estradiol and levomefolate calcium
Drug groups [BR:br08330]
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
D12130 Drospirenone, ethinyl estradiol and levomefolate calcium
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D12130
|
| Other DBs |
|
| LinkDB |
|